ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

April 15, 2011

Concepts Approved For Developmental Therapeutics Program

June 19, 1987

NCI audit Verifies Accuracy Of NSABP’s Lumpectomy Trial, B-06; Finds No Evidence Of Misrepresentation

October 21, 1994

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

HHS Secretary Tommy Thompson announced his resignation.

December 3, 2004

In Brief: McDonald, Coolidge Lead ACS; Medals Awarded To Rosenberg, Boutwell, LeMaistre

November 27, 1998